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Background: Although there are a number of reports regarding the toxicity evaluation of 
inorganic nanoparticles, knowledge on biodegradable nanomaterials, which have always been 
considered safe, is still limited. For example, the toxicity of chitosan nanoparticles, one of the 
most widely used drug/gene delivery vehicles, is largely unknown. In the present study, the 
zebrafish model was used for a safety evaluation of this nanocarrier.
Methods: Chitosan nanoparticles with two particle sizes were prepared by ionic cross-linking of 
chitosan with sodium tripolyphosphate. Chitosan nanoparticles of different concentrations were 
incubated with zebrafish embryos, and ZnO nanoparticles were used as the positive control.
Results: Embryo exposure to chitosan nanoparticles and ZnO nanoparticles resulted in a 
decreased hatching rate and increased mortality, which was concentration-dependent. Chitosan 
nanoparticles at a size of 200 nm caused malformations, including a bent spine, pericardial 
edema, and an opaque yolk in zebrafish embryos. Furthermore, embryos exposed to chitosan 
nanoparticles showed an increased rate of cell death, high expression of reactive oxygen species, 
as well as overexpression of heat shock protein 70, indicating that chitosan nanoparticles can 
cause physiological stress in zebrafish. The results also suggest that the toxicity of   biodegradable 
nanocarriers such as chitosan nanoparticles must be addressed, especially considering the in vivo 
distribution of these nanoscaled particles.
Conclusion: Our results add new insights into the potential toxicity of nanoparticles produced 
by biodegradable materials, and may help us to understand better the nanotoxicity of drug 
delivery carriers.
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Introduction
With the rapid development of nanotechnology, there is a growing interest in the 
application of nanomaterials in various fields, such as photonics, catalysis, magnetics, 
and biotechnology including cosmetics, pharmaceutics, and medicines.1–4 There are 
several reports regarding the toxicity evaluation of inorganic nanomaterials.5,6 However, 
little is known about the potential toxicity of nanoparticles used in targeted drug delivery 
and gene therapies in terms of human health. The risk these nanoparticles may pose 
to human health must be addressed, because it has been shown that nanoparticles can 
be administered to the human body by several routes, including inhalation, ingestion, 
dermal penetration, and injection, followed by distribution of these nanoparticles to 
various tissues through the systemic circulation.7,8
Until now, various site-specific drug targeting strategies using nanoparticle drug 
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systems have been introduced in the treatment of various 
diseases.9,10 Chitosan [poly (1,4-β-d-glucopyranosamine)], 
a natural polysaccharide prepared by N-deacetylation of 
chitin, has great potential as a biomaterial for the con-
struction of nanosized drug carriers and gene transfer 
vectors. These carriers have been the focus of considerable 
attention due to their many advantages, including good 
stability and simple preparation.9 In addition, chitosan 
nanoparticles can facilitate drug delivery across cellular 
barriers and transiently cause opening of the tight junc-
tions between epithelial cells.11 Therefore, the possibility 
exists that chitosan nanoparticles may translocate from 
the gastrointestinal tract, nasal cavity, or alveolar sacs into 
the systemic circulation, thereby causing toxicity to the 
human body. Several studies addressing the cytotoxicity 
of chitosan nanoparticles have been reported.12–15 It was 
shown that chitosan nanoparticles with a particle size of 
40 nm elicited dose-dependent inhibitory effects on the 
proliferation of a tumor cell line, and it appeared that 
chitosan nanoparticles had much higher cytotoxicity than 
chitosan.15 Other reports also indicated that chitosan nano-
particles (110–390 nm) had cytotoxicity profiles against 
A549 cells comparable with those of the corresponding 
dissolved   chitosan materials, with cell viability generally 
not affected by sample concentrations lower than 740 µg/
mL.12,14 Further, researchers have recently used live human 
cells to examine the uptake and cytotoxicity of chitosan 
nanoparticles, and found that they could be internalized 
by the cells, reducing cell viability and proliferation and 
compromising cell membrane integrity.13 However, the 
toxicity profile of chitosan nanoparticles in the body has 
seldom been investigated. Due to their special physico-
chemical properties, including a large surface area that can 
enhance their biological effect, nanoparticles may cause 
toxicity after entering the body.16 Therefore, evaluation of 
the potential toxic effects of these nanoparticles in the body 
is required, given that specific mechanisms and pathways 
through which nanoparticles may exert their toxic effects 
remain largely unknown. Until now, there has been little 
information on the impact of chitosan nanoparticles on 
human health. Further, systems for evaluation of nanopar-
ticle toxicity are not well established. ZnO nanoparticles 
were previously evaluated for toxicity using a zebrafish 
model,5,6 and it was found that these nanoparticles caused 
toxicity to zebrafish embryos and larvae, reducing the 
hatching rate and causing pericardial edema. In the present 
study, we used ZnO nanoparticles as a positive control to 
evaluate the toxicity of chitosan nanoparticles.
Recently, the zebrafish has become a prominent vertebrate 
model for assessing the toxicity of drugs and chemicals.17–20 
The zebrafish offers a variety of advantages as a desirable 
model for in vivo high-throughput drug screening. It is low 
cost and transparent, and its small size allows it to be assayed 
in 96-well plates. The embryos can develop promptly into 
larvae within 5 days of fertilization. As a vertebrate, the 
genomes of zebrafish and humans are closely related.19,21 
The zebrafish is also an ideal model for the screening of 
different nanomaterials and for obtaining nanotoxicity 
information at the whole animal level, which can then be 
extrapolated to humans and other vertebrates.6,22 As shown 
in Figure 1, nanotoxicity could be evaluated in a zebrafish 
model, and these toxicities, including a lower hatching rate, 
mortality, and malformations could be observed.
In this study, we prepared chitosan nanoparticles based on 
ionic gelation of chitosan with tripolyphosphate anions and 
used the zebrafish embryo as a rapid, medium throughput, 
cost-effective whole animal model to assess the toxicity of the 
biodegradable drug/gene carrier, ie, chitosan   nanoparticles. 
Our results demonstrate that chitosan nanoparticles of 
  different particle sizes could cause concentration-dependent 
toxicity with regard to hatching, growth, and development 
of zebrafish embryos. Furthermore, it was demonstrated 
that embryos exposed to chitosan nanoparticles exhibited 
an increased rate of cell death and enhanced expression of 
reactive oxygen species, as well as overexpression of heat 
shock protein 70 (HSP70), indicating that chitosan nano-
particles cause damage to zebrafish embryos. We hope that 
our discoveries will provide more insight into the potential 
toxicity of nanoparticles produced by biodegradable materi-
als and will help in understanding better the nanotoxicity of 
drug delivery carriers.
Nanoparticles
Toxicity
evaluation
Hatching rate
Sublethal toxicity
Mortality
Developmental abnormalities
Non-depleted or malformed yolk
Malformations of spine, tail, and caudal fin
Formations around the pericardial sacs or
yolk
Delayed hatching
Stunted body or eye growth
Degraded and opaque tissues
Uncharacterized chorionic excretions
Edema in the body cavity, pericardial sac,
or yolk sac regions
+
Figure 1 Toxicity evaluation of nanoparticles using zebrafish model.18
reprinted from Adv Drug Deliv Rev, vol 61, issue 6, Fako and Furgeson, Zebrafish as a 
correlative and predictive model for assessing biomaterial nanotoxicity, p. 478–486, 
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Materials and methods
Experimental fish
Zebrafish (Danio rerio), 1 year of age and 2–3 cm in 
length, were kept in recirculating water at 26°C, and fed 
with   commercial pellets at a daily ration of 0.7% of their 
body weight. All fish were held in the laboratory for at least 
two weeks prior to the experiments for acclimatization and 
evaluation of overall fish health. The authors certify that all 
experiments with live animals were performed in   compliance 
with the relevant laws, and the institutional committees 
approved our experiments.
Materials
Chitosan (85% deacetylation, molecular weight 105 Da) 
was purchased from Yuhuan Oceanic Biochemistry (Tai-
zhou, China). ZnO (.98% pure as determined by the 
manufacturer) with a particle size of 30 nm was purchased 
for Hangzhou Wan Jing Biotechnology Co Ltd (Hangzhou, 
China). Bovine serum albumin and a 2′,7′-dichlorodihy-
drofluorescein   diacetate (H2DCF-DA) fluorescent probe 
was purchased from Sigma-Aldrich Inc (St Louis, MO). 
Nitrocellulose   membrane (Hybond) was obtained from 
Amersham   Pharmacia,   Piscataway, NJ. Rabbit antirat HSP70 
antibody and   horseradish peroxidase-labeled antirabbit IgG 
were purchased from Wuhan Boshide Company (Wuhan, 
China). Acridine orange was purchased from Beyotime 
(Shanghai, China).
Preparation and characterization  
of nanoparticles
Chitosan solution 2.5 mg/mL was prepared by dissolving 
the polymer in 1% (v/v) acetic acid aqueous solution for 
0.5 hours under magnetic stirring. The pH of the solution 
was adjusted to 5.0–6.0 using 1 mol/L NaOH. The chitosan 
solution was then stirred for 0.5 hours at room temperature. 
Finally, sodium tripolyphosphate (TPP), the counter ion, was 
dissolved in pure water to prepare a 1 mg/mL solution, and 
added to the chitosan solution under mild magnetic stirring 
to form chitosan nanoparticles. The nanoparticle solution 
was centrifuged at 18,000 rpm and 4°C for 30 minutes, 
after which the nanoparticles at the bottom were collected, 
extensively washed with water to remove the TPP and the 
acetic acid, and finally lyophilized. By adjusting the mass 
ratio of TPP and chitosan, chitosan nanoparticles of different 
sizes could be prepared.
ZnO nanoparticles 100 mg/L were prepared in zebrafish 
culture medium (consisting of 64.75 mg/L NaHCO3, 
5.75 mg/L KCl, 123.25 mg/L, MgSO4 ⋅ 7H2O, and 294 mg/L 
CaCl2 ⋅ 2H2O), which was prepared according to the 
  International Organization for Standardization, Geneva, 
Switzerland, standard 7346-3:199623 as the stock solution.
Morphological examination of the nanoparticles was 
performed by transmission electron microscopy. The 
nanoparticles were stained with 2% (w/v) phosphotung-
stic acid   solution for 10 seconds, immobilized on copper 
grids with formvar, and dried overnight before micros-
copy. The   particle sizes were determined by laser diffrac-
tion spectrometry (Malvern Zetasizer 3000HS; Malvern,   
Worcestershire, UK).
Exposure of zebrafish embryos  
to nanoparticles
Zebrafish embryos were collected 4–5 hours post-fertilization 
from the zebrafish aquarium at the Department of Pharmacy, 
Zhejiang University, and staged according to standard 
  procedures.23 For the toxicity studies, 20 healthy embryos 
were transferred to the wells of a 24-well plate along with 
2 mL of zebrafish culture medium. Different concentrations 
of chitosan nanoparticles (10, 20, and 40 µg/mL), with par-
ticle sizes of 200 nm or 340 nm and dissolved using zebrafish 
culture medium were added to the wells and incubated for 
72 hours at 28.5°C. ZnO nanoparticles 10 mg/L was used 
as a positive control. Tests were performed in triplicate. The 
hatching rate, mortality, and malformations of zebrafish 
embryos at 96 hours post-fertilization were observed 
under stereomicroscopes (Jiangnan, China) to evaluate the 
  toxicity of the chitosan nanoparticles. The mortality rate was 
expressed as the number of dead embryos after 96 hours 
post-fertilization as compared with the control group. The 
hatching rate was expressed as the number of embryos that 
had hatched by 96 hours post-fertilization, as compared 
with the control group. Morphological anomalies, including 
chorion with attached debris, delayed development, lack 
of spontaneous movement at 24 hours post-fertilization, 
  pericardial edema, yolk sac edema, bent trunk, tail malforma-
tion, and an uninflated swim bladder were observed under 
stereomicroscopes.
Acridine orange staining
To investigate the role of apoptosis in the toxicity of 
  chitosan nanoparticles, acridine orange staining of 
  nanoparticle-treated or -untreated embryos was performed.24 
After exposure to 200 nm chitosan nanoparticles for 96 hours 
post-fertilization, the embryos were taken out, washed 
using   phosphate-buffered saline, transferred to Eppendorf 
tubes, and stained with 100 µL acridine orange 5 µg/mL for International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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20   minutes at room temperature. The embryos were then 
rinsed quickly in phosphate-buffered saline before being 
examined under an inverse microscope.
Analysis of intracellular reactive oxygen 
species in zebrafish embryos
To determine the mechanisms underlying chitosan 
  nanoparticle-mediated toxicity, intracellular reactive   oxygen 
species were examined in zebrafish embryos because these 
have been implicated in the oxidative stress associated 
with nanotoxicity.25 Intracellular reactive oxygen species 
were measured by flow cytometry using a cell-permanent 
H2DCF-DA fluorescent probe as a reactive oxygen spe-
cies indicator. The acetates of colorless H2DCF-DA are 
cleaved by intracellular esterase and converted to fluorescent 
(dichloro) fluorescein in the presence of reactive oxygen 
species, which can be detected by flow cytometry. For reac-
tive oxygen species analyses, the larvae were collected at 
96 hours post-fertilization and rinsed quickly using culture 
medium. Homogenation was conducted to prepare a single 
cell suspension. The cell suspension obtained was incubated 
with 1.25 mg/L H2DCF-DA for 20 minutes in the dark and 
at 28.5°C in a fish room. The cells were then washed and 
resuspended in phosphate-buffered saline. The cells were 
subsequently analyzed by flow cytometry using a FACScan 
flow cytometer (Becton Dickinson, San Jose, CA). At least 
10,000 events were collected. The analysis was performed 
using Cell Quest Software (Becton Dickinson).
Western blot analysis
To investigate the developmental toxicity of chitosan 
nanoparticles and to compare the toxicity caused by ZnO 
  nanoparticles, Western blot analysis was performed to 
evaluate the protein expression of HSP70 in whole zebrafish 
larvae. The larvae were collected and rinsed with phosphate-
buffered saline, followed by extraction of protein. The same 
amount of protein extracts from zebrafish larvae were loaded 
on each lane, electrophoresed and subsequently blotted on a 
nitrocellulose membrane (Hybond). The membrane was then 
blocked in Tris-buffered saline containing 2% bovine serum 
albumin and 0.05% Tween-20 at 4°C overnight and then incu-
bated with rabbit antirat HSP70 antibody (1:2000) at 37°C for 
2 hours, followed by staining with   horseradish peroxidase-
labeled antirabbit IgG. After washing with   Tris-buffered 
saline for three times, the membrane was incubated with a 
horseradish peroxidase-conjugated secondary antibody and 
visualized with an enhanced   chemiluminescence detection 
system and X-ray film.
statistical analysis
Statistical evaluation of differences between experimen-
tal group means was done by analyses of variance and 
Student’s t-tests using Excel software (v 2003; Microsoft, 
Inc, Redmond, WA), and the results are presented as the 
mean ± standard error of the mean. A value of P , 0.05 was 
considered to be statistically significant and P , 0.01 was 
considered to be very significant. Data points were obtained 
from at least three independent experiments.
Results
characterization of nanoparticles
Chitosan nanoparticles with two kinds of particle size were 
successfully prepared by ionic cross-linking of chitosan 
with TPP. As shown in Figure 2, the chitosan nanoparticles 
maintained a round shape with an almost homogeneous 
structure, being on average 200 ± 6 nm and 340 ± 10 nm 
in diameter.
Toxicity of chitosan nanoparticles  
in zebrafish embryos
To assess the toxicity of the chitosan nanoparticles, the 
zebrafish embryo model was used to determine whether and 
how chitosan nanoparticles influence embryonic   development. 
In this study, zebrafish embryos were exposed to chitosan 
nanoparticles for 96 hours, and dose-dependent inhibition 
of embryo hatching was induced by chitosan nanoparticles 
of different particle sizes, as shown in Figure 3. Compared 
with the control group, a significant decrease (P , 0.05) in 
hatching rate was observed at 20 mg/L and 40 mg/L concen-
trations for the 340 nm chitosan nanoparticles (Figure 3A). 
For the 200 nm chitosan nanoparticles, as compared with the 
control group, a significant or very significant decrease in 
hatching rate was observed for 30 mg/L and 40 mg/L chitosan 
nanoparticles (200 nm), respectively (Figure 3B). Therefore, 
at high concentrations, the chitosan nanoparticles had toxic 
effects on the zebrafish embryos.
As shown in Figure 3C and D, a toxic effect of the chitosan 
nanoparticles was also detected by observation of mortality 
among zebrafish embryos. Mortality was both dose-depen-
dent and time-dependent (data not shown). As compared 
with the control group, both 30 mg/L chitosan nanoparticles 
(200 nm) and 40 mg/L chitosan nanoparticles (340 nm) has 
significant effects on mortality in zebrafish embryos. All the 
embryos died after exposure to the 40 mg/L chitosan nano-
particles (200 nm) within 96 hours of   exposure. Also, sur-
viving embryos in the 5 mg/L group (200 nm) showed signs 
of malformation, including a bent spine and an opaque yolk International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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(Figure 3E and F) as compared with   controls (Figure 3G). 
The rate of malformation was increased with increasing chi-
tosan nanoparticle concentration.   However, embryos treated 
with 340 nm chitosan nanoparticles showed no significant 
malformations when compared with the 200 nm chitosan 
nanoparticle-treated group. Therefore, 200 nm chitosan 
nanoparticles had greater toxic effects than 340 nm chitosan 
nanoparticles on zebrafish embryos.
chitosan nanoparticle-induced  
cellular apoptosis
To determine whether in vivo chitosan nanoparticle exposure 
induced cellular apoptosis in the zebrafish embryo, acridine 
orange staining was performed to detect cellular death in live 
embryos. Acridine orange is a nucleic acid-selective metachro-
matic dye, which emits green fluorescence upon intercalation 
with DNA and RNA, and is widely used for detecting sites of 
apoptosis in zebrafish. Acridine orange can permeate apoptotic 
cells and binds to DNA, whereas normal cells are nonperme-
able to acridine orange. Cellular apoptosis was determined 
using acridine orange staining of larvae exposed to chitosan 
nanoparticles at 96 hours   post-fertilization. In the control group, 
low natural fluorescence was observed, while a bright green 
spot could be observed on the larvae exposed to both 20 mg/L 
and 30 mg/L chitosan nanoparticles (Figure 4A), indicating 
that these particles could cause cellular apoptosis.
Analysis of intracellular reactive oxygen 
species in zebrafish embryos
To  determine  the  mechanism  underlying  chitosan 
  nanoparticle-mediated toxicity, intracellular reactive   oxygen 
species were measured.25 In the present study, we tried to 
measure and compare intracellular reactive oxygen spe-
cies in an embryonic cell suspension treated with chitosan 
nanoparticles. It was shown that the percentages of positive 
cells in 5 mg/L treated groups (31.1% ± 1.89%) were all 
significantly higher (P , 0.01) than in the control groups 
(10.0% ± 0.87%, Figure 4B). Therefore, an increase in 
reactive oxygen species was found in embryos exposed to 
5 mg/L chitosan nanoparticles, indicating that a higher level 
of cellular oxidative stress may be caused by treatment with 
chitosan nanoparticles. This increase in reactive oxygen 
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species may be associated with the observed developmental 
toxicity of chitosan nanoparticles.
Western blot analysis of HsP70 protein
In order to characterize HSP70 expression, we examined 
protein expression in zebrafish larvae using Western blot 
analysis. HSP70 protein in control embryos is detectable. 
Following 96 hours of exposure to 200 nm chitosan nano-
particles, HSP70 protein levels increased significantly in the 
larvae (Figure 4C). Elevated HSP70 expression was also 
evident in the ZnO group, indicating that both 30 nm ZnO 
nanoparticles and chitosan nanoparticles could be stressful 
stimuli for zebrafish embryos.
Discussion
Zebrafish embryos have several advantages as an animal 
model for the study of nanoparticle toxicity. Zebrafish have 
recently emerged as a model for toxicological study of 
various nanoparticles. For example, 30 nm ZnO nanoparticles 
were found to cause dose-dependent toxicity in zebrafish 
embryos. When the concentrations exceeded 2 mg/L, death 
of the zebrafish occurred and mortality increased with increas-
ing particle concentration. Furthermore, 100% mortality was 
observed at a concentration of 30 mg/L,5 and 80 nm copper 
nanoparticles were found to be acutely toxic to zebrafish, 
with a 48-hour LC50 concentration of 1.5 mg/L.26 It was also 
demonstrated that exposure to single-walled carbon nanotubes 
induces significantly delayed hatching in zebrafish embryos 
52–72 hours post-fertilization at concentrations greater than 
120 mg/L.27 Although many studies have reported   nanoparticle 
toxicity using the zebrafish model, these embryo toxicity 
studies were mostly carried out in relation to an evaluation of 
the toxicity of environmental nanoparticles/pollutants.22,27–29 
  Relatively few studies have used zebrafish to evaluate the toxic-
ity of nanocarriers, such as biodegradable   nanoparticles, which 
are widely used in the   pharmaceutical area. Because these 
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nanomaterials possess unique physical and surface properties, 
they have inspired plans for a wide spectrum of applications, 
such as target-specific vehicles for in vivo sensing, diagnosis, 
and therapy (eg, nanomedicine, drug delivery). However, after 
entering the body, they may show cytotoxicity and immune 
toxicity because of their distribution in the body, changes 
in cellular affinity, and increased cellular uptake.30–32 After 
systemic administration, these nanoparticles are small enough 
to penetrate very small   capillaries throughout the body, and 
therefore could be a very effective approach to target certain 
tissues33 and may affect the physiology of many cells in the 
animal body.34
Several reports have shown that nanoparticles can enter 
the brain and cause tissue injury.4,35 Therefore, evaluation 
of the toxicity of these nanocarriers is important for human 
health. Unfortunately, the evaluation of nanoparticle toxic-
ity remains limited. In the present study, zebrafish embryos 
were explored as an effective model for toxicity evaluation 
of   chitosan nanoparticles. No apparent toxic effects were 
observed for chitosan nanoparticles at low concentrations. 
However, death and malformation of zebrafish embryos 
occurred with increasing chitosan nanoparticle   concentrations. 
Almost 100% mortality was observed at a concentration of 
40 mg/L for the 200 nm chitosan nanoparticles. Therefore, the 
toxicity was dose-dependent and should be considered at high 
concentrations. Although there was no decrease in hatching 
rate or mortality at a concentration of 5 mg/L for both 200 nm 
and 300 nm chitosan nanoparticles, malformation was found 
at this concentration for 200 nm chitosan nanoparticles, 
while no malformation was detected for 300 nm chitosan 
nanoparticles. Therefore, the 200 nm nanoparticles showed 
higher toxicity than the 300 nm nanoparticles in the zebrafish 
embryo model. Meanwhile, 200 nm chitosan nanoparticles 
at a concentration of 5 mg/L were examined for production 
of reactive oxygen species in zebrafish embryos, and higher 
levels were detected, which confirms the toxic effect caused 
by the 5 mg/L nanoparticles.
From the description in a review paper,9 chitosan 
nanoparticles are a promising system for drug delivery 
because of their biodegradability, biocompatibility, and good 
stability. They have been reported to have key applications 
in various areas including parenteral drug delivery, oral 
administration of drugs, vaccine delivery, ocular drug 
delivery, and brain targeting drug delivery.9 The preparation of 
chitosan nanoparticles was mainly by the ionotropic gelation 
method. Using this method, the chitosan nanoparticles 
prepared were mostly around 200–400 nm diameter, which 
was normally used in the drug delivery system. For example, 
estradiol-loaded chitosan nanoparticles with an average size 
of 269.3 ± 31.6 nm were prepared by Wang et al.36 Aktas 
et al prepared chitosan nanoparticles containing a caspase 
inhibitor with a particle diameter (Z average) ranging from 
approximately 313 nm to 412 nm.37 Sadeghi et al38 prepared 
chitosan-insulin nanoparticles with a diameter of 250 ± 20 nm. 
It was also reported that the particle size of unloaded chitosan 
nanoparticles and doxorubicin-loaded nanoparticles was 
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259 ± 15 nm and 292 ± 42 nm, respectively.39 Recently, 
we prepared   Ganoderma lucidum polysaccharide-loaded 
chitosan nanoparticles with a mean diameter of 217 ± 6 nm.40 
Following on from the aforementioned literature reports, we 
prepared blank   chitosan nanoparticles of two different sizes, 
ie, 200 ± 6 nm and 340 ± 10 nm, for toxicity evaluation in 
zebrafish.
The mechanism underlying the toxicity of chitosan 
nanoparticles was also explored by evaluation of cellular 
apoptosis, expression of reactive oxygen species, and 
HSP70. As shown by acridine orange staining, apopto-
sis could be seen in the embryos after exposure to the 
  nanoparticles. Increased production of intracellular reac-
tive oxygen species was also detected, indicating chitosan 
nanoparticles caused oxidative stress, as a result of the 
observed toxicity in zebrafish embryos. We also observed 
higher expression of HSP70 protein in the nanoparticle-
exposed group, indicating stress was caused by the chitosan 
nanoparticles. Heat shock proteins could be induced by a 
variety of stimuli, and are potentially damaging to the cell. 
They are associated with many cellular processes including 
protein synthesis, folding and translocation, and assembly 
of larger protein complexes, all of which can be impaired 
by stress.41 HSP70, one of the major heat shock proteins, is 
usually expressed at low levels, but increases in response 
to environmental and physiological stressors.42 HSP70 is 
conserved throughout evolution and has been shown to 
protect cells against induction of cell death by a variety of 
stresses and different modes of cell death.42
Although more and more research is being done using the 
zebrafish model for drug discovery and drug screening,20,43 
few studies have assessed the toxicity of nanocarriers using 
this model. Here, we first report concentration-dependent 
toxicity of biodegradable chitosan nanoparticles. However, in 
evaluation of nanoparticle toxicity, the surface area,   surface 
charge, coating, material solubility, and exposure time 
are also expected to play important roles, and thus should 
be   carefully considered in future work.
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